Log In
Print
BCIQ
Print
Print this Print this
 

PQ912

  Manage Alerts
Collapse Summary General Information
Company Probiodrug AG
DescriptionGlutaminyl cyclase (QC) inhibitor
Molecular Target Glutaminyl cyclase (QC)
Mechanism of ActionGlutaminyl cyclase (QC) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today